Research and Grants | The Cure Starts Now

The Cure Starts Now has funded $18,897,055 in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 119 grants at over 100 hospitals in 17 countries.


Ann and Robert H. Lurie Children's Hospital of Chicago - $100,000

Amount
$100,000.00
Date
November 2013

Ex-vivo expanded natural killer (NK) cells to target DIPG tumor cells in pre-clinical studies

The Hospital of Sick Children - $100,000

Amount
$100,000.00
Date
November 2013

Investigating Mechanisms of Therapeutic Resistance in DIPG.

Dana-Farber Cancer Institute - $50,000

Amount
$50,000.00
Date
November 2013

Phase II Trial of Molecularly Determined Treatment of Children and Young Adults with Newly Diagnosed Diffuse Intrinsic Pontine Gliomas.

Texas Children's Cancer Center - $100,000

Amount
$100,000.00
Date
November 2013

Targeting DIPGs in vivo in Intra-brain Stem Xenograft Mouse Models through Combined Radiation and Oncolytic Viral Therapy.

Children's National Medical Center - $99,979

Amount
$99,979.00
Date
November 2013

Comparative Proteomic and RNA Sequencing of DIPGs

Sydney Children's Hospital - $100,000

Amount
$100,000.00
Date
January 2013

Research of treatments for Diffuse Intrinsic Pontine Glioma (DIPG)

Stanford University Medical Center - $35,589

Amount
$35,589.00
Date
October 2012

A Combinatorial Approach to Target Cellular Subpopulations in DIPG

Texas Children's Cancer Center - $100,000

Amount
$100,000.00
Date
October 2012

Preclinical Evaluation of Novel BMI-1 Inhibitors In Vivo in Intra-Brainstem Orthotopic Xenograft Mouse Models